145 related articles for article (PubMed ID: 23298577)
21. Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker.
Kaminskas LM; Kelly BD; McLeod VM; Sberna G; Owen DJ; Boyd BJ; Porter CJ
J Control Release; 2011 Jun; 152(2):241-8. PubMed ID: 21315119
[TBL] [Abstract][Full Text] [Related]
22. Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of amphotericin B: formulation development and in vitro and in vivo evaluation.
Jain K; Verma AK; Mishra PR; Jain NK
Antimicrob Agents Chemother; 2015 May; 59(5):2479-87. PubMed ID: 25645852
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization and brain targeting potential of paclitaxel loaded thiamine-PPI nanoconjugates.
Patel SK; Gajbhiye V; Jain NK
J Drug Target; 2012 Dec; 20(10):841-9. PubMed ID: 22994427
[TBL] [Abstract][Full Text] [Related]
24. Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers.
Birdhariya B; Kesharwani P; Jain NK
Drug Dev Ind Pharm; 2015; 41(8):1393-9. PubMed ID: 25163759
[TBL] [Abstract][Full Text] [Related]
25. In vivo toxicity of poly(propyleneimine) dendrimers.
Ziemba B; Janaszewska A; Ciepluch K; Krotewicz M; Fogel WA; Appelhans D; Voit B; Bryszewska M; Klajnert B
J Biomed Mater Res A; 2011 Nov; 99(2):261-8. PubMed ID: 21976451
[TBL] [Abstract][Full Text] [Related]
26. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
27. Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes.
Pruthi J; Mehra NK; Jain NK
J Drug Target; 2012 Aug; 20(7):593-604. PubMed ID: 22690657
[TBL] [Abstract][Full Text] [Related]
28. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.
Agrawal P; Gupta U; Jain NK
Biomaterials; 2007 Aug; 28(22):3349-59. PubMed ID: 17459469
[TBL] [Abstract][Full Text] [Related]
29. Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver.
Vyas SP; Subhedar R; Jain S
J Pharm Pharmacol; 2006 Mar; 58(3):321-6. PubMed ID: 16536898
[TBL] [Abstract][Full Text] [Related]
30. Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes.
Ruckmani K; Sankar V; Sivakumar M
J Biomed Nanotechnol; 2010 Feb; 6(1):43-51. PubMed ID: 20499831
[TBL] [Abstract][Full Text] [Related]
31. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers.
Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK
Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354
[TBL] [Abstract][Full Text] [Related]
32. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting.
Bhadra D; Yadav AK; Bhadra S; Jain NK
Int J Pharm; 2005 May; 295(1-2):221-33. PubMed ID: 15848007
[TBL] [Abstract][Full Text] [Related]
33. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer.
Agashe HB; Dutta T; Garg M; Jain NK
J Pharm Pharmacol; 2006 Nov; 58(11):1491-8. PubMed ID: 17132212
[TBL] [Abstract][Full Text] [Related]
34. Self-assembled drug delivery systems. Part 4. In vitro/in vivo studies of the self-assemblies of cholesteryl-phosphonyl zidovudine.
Jin Y; Xing L; Tian Y; Li M; Gao C; Du L; Dong J; Chen H
Int J Pharm; 2009 Oct; 381(1):40-8. PubMed ID: 19646518
[TBL] [Abstract][Full Text] [Related]
35. Reducing cytotoxicity while improving anti-cancer drug loading capacity of polypropylenimine dendrimers by surface acetylation.
Wang F; Cai X; Su Y; Hu J; Wu Q; Zhang H; Xiao J; Cheng Y
Acta Biomater; 2012 Dec; 8(12):4304-13. PubMed ID: 22842039
[TBL] [Abstract][Full Text] [Related]
36. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity.
Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B
Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301
[TBL] [Abstract][Full Text] [Related]
37. Improved brain delivery and in vitro activity of zidovudine through the use of a redox chemical delivery system.
Mizrachi Y; Rubinstein A; Harish Z; Biegon A; Anderson WR; Brewster ME
AIDS; 1995 Feb; 9(2):153-8. PubMed ID: 7718185
[TBL] [Abstract][Full Text] [Related]
38. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent.
Agarwal A; Gupta U; Asthana A; Jain NK
Biomaterials; 2009 Jul; 30(21):3588-96. PubMed ID: 19344947
[TBL] [Abstract][Full Text] [Related]
39. Methotrexate-conjugated PEGylated dendrimers show differential patterns of deposition and activity in tumor-burdened lymph nodes after intravenous and subcutaneous administration in rats.
Kaminskas LM; McLeod VM; Ascher DB; Ryan GM; Jones S; Haynes JM; Trevaskis NL; Chan LJ; Sloan EK; Finnin BA; Williamson M; Velkov T; Williams ED; Kelly BD; Owen DJ; Porter CJ
Mol Pharm; 2015 Feb; 12(2):432-43. PubMed ID: 25485615
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of surface engineered PPI dendrimers for targeted drug delivery.
Kaur A; Jain K; Mehra NK; Jain NK
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):414-425. PubMed ID: 27027686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
